Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trial

Bibliographic Details
Title:	Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trial
Authors:	Ferreira, Marion, Bejan-Angoulvant, Theodora, Marchand-Adam, Sylvain, Mousset, Elodie, Mureau, Elody, Jouneau, Stéphane, Nunes, Hilario, Montani, David, Chenivesse, Cécile, Cadranel, Jacques, Bonniaud, Philippe, Crestani, Bruno, Cottin, Vincent, Caille, Agnès
Source:	In Respiratory Medicine and Research May 2025 87
Database:	ScienceDirect

More Details
ISSN:	25900412
DOI:	10.1016/j.resmer.2024.101144
Published in:	Respiratory Medicine and Research
Language:	English